Characterization of Aspergillus spp. isolated from patients with coronavirus disease 2019

[1]  E. Mellado,et al.  COVID-19 Associated Pulmonary Aspergillosis (CAPA): Hospital or Home Environment as a Source of Life-Threatening Aspergillus fumigatus Infection? , 2022, Journal of fungi.

[2]  J. Zahar,et al.  A review of significance of Aspergillus detection in airways of ICU COVID‐19 patients , 2021, Mycoses.

[3]  W. Chong,et al.  Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review , 2021, Journal of Hospital Infection.

[4]  K. Uchida,et al.  COVID-19-associated pulmonary aspergillosis in a Japanese man: A case report , 2021, Journal of Infection and Chemotherapy.

[5]  C. Clancy,et al.  Invasive mould disease in fatal COVID-19: a systematic review of autopsies , 2021, The Lancet Microbe.

[6]  J. Perfect,et al.  Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance , 2020, The Lancet Infectious Diseases.

[7]  E. Kuijper,et al.  Paradoxal Trends in Azole-Resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013–2018 , 2020, Emerging infectious diseases.

[8]  T. Rogers,et al.  Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination , 2020, Medical Mycology Case Reports.

[9]  J. Farooqi,et al.  COVID‐19‐associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID‐19 pneumonia: An observational study from Pakistan , 2020, Mycoses.

[10]  M. Hoenigl,et al.  Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19 , 2020, Open forum infectious diseases.

[11]  B. Mégarbane,et al.  Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19 , 2020, The Lancet Respiratory Medicine.

[12]  P. van Wijngaarden,et al.  COVID-19–associated Pulmonary Aspergillosis , 2020, American journal of respiratory and critical care medicine.

[13]  M. Hallek,et al.  COVID‐19 associated pulmonary aspergillosis , 2020, Mycoses.

[14]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[15]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[16]  P. Escribano,et al.  Comparison of Two Highly Discriminatory Typing Methods to Analyze Aspergillus fumigatus Azole Resistance , 2018, Front. Microbiol..

[17]  O. Cornely,et al.  EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis , 2018, Mycoses.

[18]  S. Clarke,et al.  Secondary Bacterial Infections Associated with Influenza Pandemics , 2017, Front. Microbiol..

[19]  H. Gil,et al.  A New Aspergillus fumigatus Typing Method Based on Hypervariable Tandem Repeats Located within Exons of Surface Protein Coding Genes (TRESP) , 2016, PloS one.

[20]  Cécile Viboud,et al.  Association between Respiratory Syncytial Virus Activity and Pneumococcal Disease in Infants: A Time Series Analysis of US Hospitalization Data , 2015, PLoS medicine.

[21]  T. Peláez,et al.  Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  T. Nishino,et al.  Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan , 2011, Antimicrobial Agents and Chemotherapy.

[23]  B. Alexander,et al.  Molecular Identification of Aspergillus Species Collected for the Transplant-Associated Infection Surveillance Network , 2009, Journal of Clinical Microbiology.

[24]  Robert George,et al.  Bacterial Pneumonia and Pandemic Influenza Planning , 2008, Emerging infectious diseases.

[25]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard , 2008 .

[27]  J. Mouton,et al.  Use of a Novel Panel of Nine Short Tandem Repeats for Exact and High-Resolution Fingerprinting of Aspergillus fumigatus Isolates , 2005, Journal of Clinical Microbiology.

[28]  D. Nickle,et al.  Aspergillus lentulus sp. nov., a New Sibling Species of A. fumigatus , 2005, Eukaryotic Cell.

[29]  Mark M Huycke,et al.  Outbreak of invasive Aspergillus infection in surgical patients, associated with a contaminated air-handling system. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  D. Reynolds,et al.  The fungal holomorph : mitotic, meiotic and pleomorphic speciation in fungal systematics : proceedings of an International Symposium, Newport, Oregon, 4-7 August, 1992 , 1993 .

[31]  T. White.  Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics , 1990 .